ELISA: 1/1,000. Western blotting: 1/100 - 1/500. Immunohistochemistry: 1/50 - 1/100. Other applications not tested. Optimal dilutions are dependent on conditions and should be determined by the user.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Liquid
Konzentration
0.25 mg/mL
Buffer
PBS with 0.09 % (W/V) sodium azide
Konservierungsmittel
Sodium azide
Vorsichtsmaßnahmen
This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Handhabung
Avoid repeated freezing and thawing.
Lagerung
4 °C/-20 °C
Informationen zur Lagerung
Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
Kan, Liu, McGuire, Berger, Awatramani, Dymecki, Kessler: "Dysregulation of local stem/progenitor cells as a common cellular mechanism for heterotopic ossification." in: Stem cells (Dayton, Ohio), Vol. 27, Issue 1, pp. 150-6, (2009) (PubMed).
Target
BMPR1B
(Bone Morphogenetic Protein Receptor, Type IB (BMPR1B))
ALK6 antikoerper, BMPR-IB antikoerper, FecB antikoerper, alk-6 antikoerper, alk6 antikoerper, cdw293 antikoerper, alk6b antikoerper, zgc:172219 antikoerper, BMPR1B antikoerper, AI385617 antikoerper, ALK-6 antikoerper, AV355320 antikoerper, Acvrlk6 antikoerper, Alk6 antikoerper, BMPR-1B antikoerper, CFK-43a antikoerper, SKR6 antikoerper, BR1b antikoerper, alk6tr antikoerper, bmpr1b antikoerper, zALK-6 antikoerper, zgc:92220 antikoerper, CDw293 antikoerper, BMP15 antikoerper, BMPRIB antikoerper, RPK-1 antikoerper, bone morphogenetic protein receptor type 1B antikoerper, bone morphogenetic protein receptor, type IBb antikoerper, bone morphogenetic protein receptor, type 1B antikoerper, bone morphogenetic protein receptor, type IBa antikoerper, BMPR1B antikoerper, bmpr1b antikoerper, bmpr1bb antikoerper, Bmpr1b antikoerper, bmpr1ba antikoerper
Hintergrund
The bone morphogenetic protein (BMP) receptors are a family of transmembrane serine/threonine kinases that include the type I receptors BMPR1A and BMPR1B and the type II receptor BMPR2. These receptors are also closely related to the activin receptors, ACVR1 and ACVR2. The ligands of these receptors are members of the TGF-beta superfamily. TGF-betas and activins transduce their signals through the formation of heteromeric complexes with 2 different types of serine (threonine) kinase receptors: type I receptors of about 50-55 kD and type II receptors of about 70-80 kD. Type II receptors bind ligands in the absence of type I receptors, but they require their respective type I receptors for signaling, whereas type I receptors require their respective type II receptors for ligand binding.Synonyms: ALK6, Bone morphogenetic protein receptor type-1B